Text Size Normal Text Sizing Button Medium Text Sizing Button Large Text Sizing Button Text Contrast Normal Contrast Button Reverse Contrast Button Switch to Spanish Language Press Room Contact Us Sitemap Sign In Register
Link to Homepage About BrightFocus
Donate Now Get Involved  
Alzheimer's Disease Research Macular Degeneration Research National Glaucoma Research

Sign up for Email Notifications
If you would like to be notified when funding or meeting opportunities are announced please click on the link below.

Sign up for new announcements.

Please add ResearchGrants@BrightFocus.org to your institution’s white list to insure that the notification is not blocked by your organization’s SPAM filters.

This email list is not sold or distributed, and serves only as an annual reminder of the availability of research support through the BrightFocus Foundation (www.brightfocus.org). Please follow instructions on the notification emails for removal requests.

BrightFocus Research Grants Funding
Grant Funding for Alzheimer's Research
Grant Funding for Macular Degeneration Research
Grant Funding for Glaucoma Research


National Glaucoma Research
Current Award

Dr. Yang Hu

Yang Hu, M.D., Ph.D.

Temple University School of Medicine
Philadelphia, PA

Title: Neuroprotection by Inhibition of ER Stress in Glaucoma
Non-Technical Title: A Novel Way to Protect Neurons and Axons in the Eyes

Acknowledgements: Recipient of the Dr. Douglas H. Johnson award for glaucoma research
Duration: July 1, 2013 - June 30, 2015
Award Type: Standard
Award Amount: $100,000


Loss of retinal ganglion cells and their axons due to optic nerve injury account for visual function deficits in glaucoma. Dr. Yang Hu’s team hypothesizes that the underlying mechanisms involve stress induced by optic nerve injury to a part of the cell where proteins are made, called the endoplasmic reticulum (ER). Dr. Hu's team propose to manipulate ER stress proteins to promote neuroprotection and therefore to preserve vision function of glaucoma patients.


In glaucoma, loss of vision is due to optic nerve (ON) injury, axon degeneration and death of retinal ganglion cells (RGCs), the nerves that are bundled into the ON. A better understanding of the mechanisms underlying RGC and ON degeneration is needed to develop novel neuroprotective treatments. In an ON crush model of glaucoma, which leads to the death of most RGCs in mouse, Dr. Hu’s team demonstrated that axon injury induces endoplasmic reticulum (ER) stress. In addition, modifying ER stress dramatically protected RGCs, suggesting the critical role of ER stress in neuronal survival. Thus, targeting ER stress may have considerable therapeutic neuroprotective potential in glaucoma.

There are three signal transduction pathways downstream of ER stress and multiple molecules in those pathways could potentially play a role in neuronal degeneration. In fact, Dr. Hu’s team has shown that manipulating two key ER stress proteins significantly promote neuroprotection of injured RGCs. Thus, the team will determine whether other molecules in the ER stress pathways also exert potent neuroprotection. In addition, they will determine whether targeting several molecules together will achieve synergistic neuroprotection. The team has identified a potentially new mechanism of neurodegeneration that links the critical stress response with optic nerve injury. New insights into the critical proteins that regulate RGC survival can be translated into novel therapeutic approaches to prevent vision loss in patients with glaucoma. Furthermore, by developing an adeno-associated virus-mediated genetic manipulation of ER stress, Dr. Hu’s team is testing the possibility of a novel gene therapy strategy to maximize neuroprotection and prevent disease progression in glaucoma patients.

Investigator Biography:

Dr. Yang Hu is an Assistant Professor of Shriners Center for Neural Repair and Rehabilitation at the Temple University School of Medicine. He was trained as an ophthalmologist in China and completed his Ph.D. studies at Cornell University Medical College and postdoctoral studies at Harvard Medical School. He has previously held positions at Beijing Friendship Hospital as a resident of ophthalmology and at Merck Research Laboratory as a senior research biologist for neurodegeneration. Dr. Hu’s laboratory focuses on understanding the mechanisms responsible for neuronal degeneration after CNS injury or diseases with the goal of building on this understanding to develop effective strategies to promote neuroprotection and functional recovery.